PALX
Palomino Laboratories Inc.
Overview
Palomino Laboratories Inc is a Other company.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
History
Earnings history
Reported quarters with consensus, surprise, and 1-day reaction context.
Track Record
SampleSpoken Alpha tracks PALX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 80% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $5.26 | $4.31 | +22.1% | -5.9% | -4.8% |
| Q4 FY2026 | $5.48 | $4.43 | +23.7% | -4.2% | -4.9% |
| Q3 FY2026 | $5.83 | $4.46 | +30.8% | -4.4% | -6.8% |
| Q2 FY2026 | $5.40 | $4.28 | +26.1% | -1.3% | +0.3% |
| Q1 FY2025 | $5.52 | $4.30 | +28.3% | +2.0% | +4.0% |
| Q4 FY2025 | $5.51 | $4.35 | +26.7% | -5.0% | -5.8% |
| Q3 FY2025 | $5.47 | $4.28 | +27.9% | -7.4% | -9.8% |
| Q2 FY2025 | $5.75 | $4.57 | +25.8% | -1.9% | -1.5% |
| Q1 FY2024 | $5.35 | $4.41 | +21.4% | +2.0% | +4.9% |
| Q4 FY2024 | $5.37 | $4.53 | +18.5% | -5.4% | -8.0% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Jeffrey B ShealyCEO9 mono recorded callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • guidance suspended Q3 FY2026
- Jason TuChief Accounting Officer9 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • guidance suspended Q3 FY2026
- Richard OgawaSecretary9 mono recorded callsCurrentSample
OTHER since 2025 • 2/4 beats (50%) • last guidance raise Q2 FY2026
- Nathan P PereiraCEO0 mono recorded callsFormerSample
CEO since 2023 • 4/12 beats (33%) • guidance suspended Q2 FY2026
Peers
Other companies in Other
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PALX.
$ curl https://api.spokenalpha.com/v1/companies/PALXFAQ
Frequently asked about PALX
Where can I find Palomino Laboratories Inc.'s (PALX) earnings call transcripts?
Spoken Alpha indexes PALX's earnings call transcripts at https://spokenalpha.com/companies/PALX. Each call links to attributed speakers and parsed analyst Q&A.
What sector is PALX in?
Palomino Laboratories Inc. (PALX) operates in the Other sector.